Larimar Therapeutics slapped with FDA clinical hold, forced to halt $95M cash raise

Larimar Therapeutics saw its shares nearly halved in after-hours trading last night after it was hit with an FDA trial hold and had to cancel a planned private raise.

Related Keywords

Carole Ben Maimon , ,Larimar Therapeutics ,Food And Drug Administration Fda ,Clinical Hold ,Genetic Diseases ,Drug Safety ,Biotech ,லாரிமார் சிகிச்சை ,மருத்துவ பிடி ,பயோடெக் ,